Sunshine Biopharma's total assets for Q4 2024 were $30.56M, an increase of 1.68% from the previous quarter. SBFM total liabilities were $7.06M for the fiscal quarter, a 40.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.